Table 2. Summary of perioperative CGM data.
CGM value | Preoperative | Intraoperative | Postoperative | p value | |
---|---|---|---|---|---|
During CIII | During SQII | (CIII vs. SQII) | |||
Mean (mg/dL) | 107.1 ± 19.3 | 143.9 ± 36.1 | 127.5 ± 8.2 | 141.3 ± 25.0 | <0.01* |
SD (mg/dL) | 21.2 ± 8.4 | 29.1 ± 20.8 | 19.5 ± 8.1 | 28.8 ± 16.3 | <0.01* |
Max (mg/dL) | 168.4 ± 38.6 | 191.4 ± 64.0 | 179.1 ± 30.5 | 219.8 ± 63.5 | <0.01* |
Min (mg/dL) | 67.9 ± 16.0 | 96.7 ± 21.1 | 90.7 ± 12.5 | 89.2 ± 17.4 | 0.46 |
≤70 mg/dL | 0.1 ± 0.6 (%) | 0.6 ± 2.6 (%) | <0.01* | ||
71–179 mg/dL | 97.1 ± 5.5 (%) | 86.4 ± 19.0 (%) | <0.01* | ||
≥180 mg/dL | 2.8 ± 5.2 (%) | 13.0 ± 18.2 (%) | <0.01* |
*Value is statistically significant. p value: Paired t-test; CGM: continuous glucose monitoring; CIII: continuous intravenous insulin infusion; SQII: subcutaneous insulin infusion; SD: standard deviation